Company intelligence / Profile preview

Neuro-Sys

Gardanne, Provence-Alpes-Côte d’Azur, Franceneuro-sys.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Neuro-Sys is a leading French CRO specializing in advanced preclinical models for neurodegenerative diseases. It provides innovative automated platforms for efficacy and mode-of-action studies using both small molecules and natural compounds. The company has received multiple awards recognizing its expertise in the field. Its proprietary CORTEX AI platform leverages artificial intelligence to enhance neuroscientific data analysis.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Small moleculesNatural extracts/compounds from medicinal plants
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Neuro-Sys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro-Sys.

Explore the full profile